Creative Planning
KNSA icon

Creative Planning’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Creative Planning’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$877K Buy
13,720
+1,033
+8% +$53.6K ﹤0.01% 2753
2026
Q1 		$611K Buy
12,687
+1,205
+10% +$53.4K ﹤0.01% 2873
2025
Q4 		$474K Sell
11,482
-1,275
-10% -$51.1K ﹤0.01% 2888
2025
Q3 		$495K Sell
12,757
-185
-1% -$6.01K ﹤0.01% 2733
2025
Q2 		$358K Buy
+12,942
New +$329K ﹤0.01% 2751

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Creative Planning's KNSA Position: Q2 2026 in Review

Creative Planning increased its Kiniksa Pharmaceuticals (KNSA) stake by 8.1% in Q2 2026, buying an estimated $53.6K and bringing the position to 13,720 shares worth $877K. The position accounts for ﹤0.01% of the portfolio, ranked #2753.

Creative Planning first reported a position in KNSA in Q2 2025 and has held it in 5 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Creative Planning held 13,720 shares of Kiniksa Pharmaceuticals worth $877K as of Q2 2026.
  • Creative Planning bought 1,033 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $53.6K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2753 holding.
  • Creative Planning first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.